OTCBB:GTHP - Guided Therapeutics Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$0.01 0.00 (0.00 %)
(As of 08/14/2018 04:53 AM ET)
Previous Close$0.01
Today's Range$0.01 - $0.01
52-Week Range$0.01 - $0.52
Volume1.04 million shs
Average Volume5.52 million shs
Market Capitalization$470,000.00
P/E RatioN/A
Dividend YieldN/A
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.

Receive GTHP News and Ratings via Email

Sign-up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCBB
Industry Electromedical equipment


Debt-to-Equity RatioN/A
Current Ratio0.04
Quick Ratio0.01


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$240,000.00
Price / Sales7.89
Cash FlowN/A
Price / CashN/A
Book Value($0.41) per share
Price / Book-0.02


EPS (Most Recent Fiscal Year)N/A
Net Income$-10,690,000.00
Net Margins-4,065.81%
Return on EquityN/A
Return on Assets-1,119.29%


Outstanding Shares189,420,000
Market Cap$470,000.00

Guided Therapeutics (OTCBB:GTHP) Frequently Asked Questions

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCBB under the ticker symbol "GTHP."

How were Guided Therapeutics' earnings last quarter?

Guided Therapeutics Inc (OTCBB:GTHP) released its quarterly earnings results on Monday, May, 21st. The medical technology company reported $0.00 EPS for the quarter. View Guided Therapeutics' Earnings History.

Who are some of Guided Therapeutics' key competitors?

Who are Guided Therapeutics' key executives?

Guided Therapeutics' management team includes the folowing people:
  • Mr. Gene S. Cartwright Ph.D., Chief Exec. Officer, Pres, Acting Chief Financial Officer and Director (Age 64)
  • Dr. Mark L. Faupel, COO & Director (Age 63)
  • Mr. Richard L. Fowler, Sr. VP of Engineering and Sec. (Age 62)
  • Mr. Charles Rufai, Controller

Has Guided Therapeutics been receiving favorable news coverage?

News articles about GTHP stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Guided Therapeutics earned a news impact score of 0.25 on Accern's scale. They also assigned news articles about the medical technology company an impact score of 45.43 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for Guided Therapeutics.

How do I buy shares of Guided Therapeutics?

Shares of GTHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Guided Therapeutics' stock price today?

One share of GTHP stock can currently be purchased for approximately $0.01.

How big of a company is Guided Therapeutics?

Guided Therapeutics has a market capitalization of $470,000.00 and generates $240,000.00 in revenue each year. Guided Therapeutics employs 10 workers across the globe.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, NORCROSS GA, 30092. The medical technology company can be reached via phone at 770-242-8723 or via email at [email protected]

MarketBeat Community Rating for Guided Therapeutics (OTCBB GTHP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Guided Therapeutics and other stocks. Vote "Outperform" if you believe GTHP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GTHP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/14/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.